![Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open](https://oncodaily.com/pub/uploads/2024/04/download-14.jpg)
Photo of Jean Zeghondy from LinkedIn
Apr 6, 2024, 10:04
Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open
Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post on LinkedIn:
“Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open.”
Read further.
Source: Jean Zeghondy/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023